Cargando…
High mobility group box-1 and its clinical value in breast cancer
BACKGROUND: High mobility group box-1 (HMGB1) is a factor regulating malignant tumorigenesis, proliferation, and metastasis, and is associated with poor clinical pathology in various human cancers. We investigated the differential concentrations of HMGB1 in tissues and sera, and their clinical value...
Autores principales: | Sun, Shanping, Zhang, Wei, Cui, Zhaoqing, Chen, Qi, Xie, Panpan, Zhou, Changxin, Liu, Baoguo, Peng, Xiangeng, Zhang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334343/ https://www.ncbi.nlm.nih.gov/pubmed/25709474 http://dx.doi.org/10.2147/OTT.S73366 |
Ejemplares similares
-
Prognostic value of the high-mobility group box-1 in young patients with chest pain
por: Haghjooy-Javanmard, Shaghayegh, et al.
Publicado: (2014) -
High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017) -
High Mobility Group Box-1: A Missing Link between Diabetes and Its Complications
por: Wu, Han, et al.
Publicado: (2016) -
The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019) -
Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
por: Pang, Xiaoao, et al.
Publicado: (2014)